Engineering platforms for biologic delivery and laboratory performance.

Mincle Co is a Sydney-based biotechnology engineering company developing patented technologies for wearable biologic delivery and advanced laboratory systems.

Our work combines life science insight, industrial design, and practical engineering to create systems designed for real-world use, partner collaboration, and commercial translation.

About Mincle

WHO WE ARE

A platform engineering company focused on practical life-science technologies.

Mincle Co develops practical engineering platforms for two high-value settings: biologic delivery beyond the clinic and laboratory workflows where stability, consistency, and repeatability matter.

Flexible pathways for pharmaceutical, life-science, and commercial partners.

For pharmaceutical partners, Mincle Co is focused on advancing wearable delivery technologies that support biologic therapy delivery beyond traditional clinical settings.

For laboratory and life-science partners, Mincle develops practical systems designed to improve workflow reliability, stability, and repeatability.

TECHNOLOGY FOCUS

Two focused platforms under one engineering philosophy

3 to 5ml Delivery system

Dr Noelle Sunstrom, PhD, MBA, FAICD Chair & Acting CEO

Dr Noelle Sunstrom brings deep biopharmaceutical leadership, scientific expertise and board-level governance experience to Mincle Co. As founder and CEO of NeuClone, she has led biosimilar development across the full biologics translation pathway, from gene and cell-line development through manufacturing, preclinical and clinical development, and strategic engagement with regulatory authorities. Her experience spans biologics development, biosimilar strategy, manufacturing translation, executive leadership and commercialisation, providing Mincle Co with strong strategic oversight as it advances technologies for biologic drug delivery and life-science applications.

Laboratory Performance Systems

Engineered mats and platforms designed to support stability, handling, and reproducibility in demanding laboratory environment

Partner-Ready Commercial Model

Licensing, co-development, distribution, and technical collaboration.

Practical Usability

Built around real people and workflows.

Jean Payette, Co-Founder / Managing Director

Industrial designer with over 10 years of experience in academia and over 12 years as Director at NeuClone, bringing design expertise to the medical equipment industry through practical, high-performance technologies and scalable solutions. Experienced in leading multidisciplinary teams across concept development, prototyping, testing, and production. Focused on creating medical technologies that balance innovation, manufacturability, and real-world healthcare demands.

Partnership pathways:

Licensing-ready technologies

Co-development partnerships

Distribution and dealership pathways

Technical collaboration and platform adaptation

Scalable commercialisation support

Laboratory Performance Systems

Engineered for stability, repeatability, and reliable workflow use.

Wearable Biologic Drug Delivery Platform

Designed for pharmaceutical co-development and platform adaptation.

Reliable Performance

Designed for demanding use environments.

Scalable Partnerships

Advanced through licensing, co-development, distribution, and partner-led commercialisation.

HEED® Wearable Delivery Platform

HEED® is a controlled wearable subcutaneous delivery platform for biologic therapies, supporting both large-volume (20mL to 60mL) and small-volume (3mL to 5mL) delivery, designed to improve the patient treatment experience while enabling pharmaceutical partners to develop integrated combination drug device solutions.

CREDIBILITY AND PROGRESS

Proof points that support partner confidence

Combination Product Readiness

HEED® is being developed as a wearable delivery platform for pharmaceutical partners seeking therapy-specific drug–device integration.

Global IP Pathway

Granted patent protection and PCT filing support an international IP strategy for the wearable delivery platform.

Protected Laboratory Mat Design

Granted patent protection supports Mincle’s laboratory mat technology, with surface features for stable vessel handling and repeatable shaker workflows.

Publication Activity

Published work on wearable devices for subcutaneous delivery of large-volume biologics.

LEADERSHIP

Leadership and strategic expertise.